Genome-wide transcriptional profiling of chronic cutaneous lupus erythematosus (CCLE) peripheral blood identifies systemic alterations relevant to the skin manifestation

Genomics

Volumn 105, Issue 2, 2015, Pages 90-100

  Dey Rao, R ^a   Sinha, A A ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Apoptosis; Blood; Cutaneous lupus; Gene expression; Interferon; Microarray

Indexed keywords

ADULT; APOPTOSIS; ARTICLE; CASE REPORT; COHORT ANALYSIS; CONTROLLED STUDY; DISCOID LUPUS ERYTHEMATOSUS; FEMALE; GENE EXPRESSION; GENE MAPPING; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; HUMAN; IMMUNE RESPONSE; MIDDLE AGED; SKIN MANIFESTATION; BLOOD; CHROMOSOME MAP; GENE EXPRESSION PROFILING; GENE LOCUS; GENETIC ASSOCIATION; GENETICS; METABOLISM; PATHOLOGY; SKIN;

ADULT; CHROMOSOME MAPPING; FEMALE; GENE EXPRESSION PROFILING; GENETIC LOCI; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUPUS ERYTHEMATOSUS, DISCOID; MIDDLE AGED; SKIN;

EID: 84922731774     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2014.11.004     Document Type: Article

References (90)

1. Wenzel J., Zahn S., Tuting T. Pathogenesis of cutaneous lupus erythematosus: common and different features in distinct subsets. Lupus 2010, 19:1020-1028.
2. Biazar C., Sigges J., Patsinakidis N., Ruland V., Amler S., Bonsmann G., Kuhn A. Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE). Autoimmun. Rev. 2013, 12:444-454. E. co-authors.
3. Abstracts from the 3rd International Conference on Cutaneous Lupus Erythematosus. J. Invest. Dermatol. 2014, 134:1483-1489.
4. Werth V.P. Cutaneous lupus: insights into pathogenesis and disease classification. Bull. NYU Hosp. Jt. Dis. 2007, 65:200-204.
5. Norris D.A., Whang K., David-Bajar K., Bennion S.D. The influence of ultraviolet light on immunological cytotoxicity in the skin. Photochem. Photobiol. 1997, 65:636-646.
6. Liu M., Bashir M., Sharma M., Xu H., Williams K., Anyanwu C., et al. Novel proinflammatory microvesicles that carry LL-37 in patients with cutaneous lupus. Arthritis Rheum. 2013, 65:1860. [abstract].
7. Mikita N., Ikeda T., Ishiguro M., Furukawa F. Recent advances in cytokines in cutaneous and systemic lupus erythematosus. J. Dermatol. 2011, 38:839-849.
8. Yu C., Chang C., Zhang J. Immunologic and genetic considerations of cutaneous lupus erythematosus: a comprehensive review. J. Autoimmun. 2013, 41:34-45.
9. Olferiev M., Lliguicota M., Kirou K.A., Crow M.K. Measuring interferon alpha and other cytokines in SLE. Methods Mol. Biol. 2014, 1134:131-150.
10. Okada Y., Shimane K., Kochi Y., Tahira T., Suzuki A., Higasa K., Takahashi A., Horita T., Atsumi T., Ishii T., Okamoto A., Fujio K., Hirakata M., Amano H., Kondo Y., Ito S., Takada K., Mimori A., Saito K., Kamachi M., Kawaguchi Y., Ikari K., Mohammed O.W., Matsuda K., Terao C., Ohmura K., Myouzen K., Hosono N., Tsunoda T., Nishimoto N., Mimori T., Matsuda F., Tanaka Y., Sumida T., Yamanaka H., Takasaki Y., Koike T., Horiuchi T., Hayashi K., Kubo M., Kamatani N., Yamada R., Nakamura Y., Yamamoto K. A genome-wide association study identified AFF1 as a susceptibility locus for systemic lupus erythematosus in Japanese. PLoS Genet. 2012, 8:e1002455.
11. Li R., Yang W., Zhang J., Hirankarn N., Pan H.F., Mok C.C., Chan T.M., Wong R.W., Mok M.Y., Lee K.W., Wong S.N., Leung A.M., Li X.P., Avihingsanon Y., Lee T.L., Ho M.H., Lee P.P., Wong W.H., Wong C.M., Ng I.O., Yang J., Li P.H., Zhang Y., Zhang L., Li W., Baum L., Kwan P., Rianthavorn P., Deekajorndej T., Suphapeetiporn K., Shotelersuk V., Garcia-Barcelo M.M., Cherny S.S., Tam P.K., Sham P.C., Lau C.S., Shen N., Lau Y., Ye D.Q. Association of CD247 with systemic lupus erythematosus in Asian populations. Lupus 2012, 21:75-83.
12. Chung S.A., Taylor K.E., Graham R.R., Nititham J., Lee A.T., Ortmann W.A., Jacob C.O., Alarcon-Riquelme M.E., Tsao B.P., Harley J.B., Gaffney P.M., Moser K.L., Petri M., Demirci F.Y., Kamboh M.I., Manzi S., Gregersen P.K., Langefeld C.D., Behrens T.W., Criswell L.A. Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production. PLoS Genet. 2011, 7:e1001323.
13. Yang J., Yang W., Hirankarn N., Ye D.Q., Zhang Y., Pan H.F., Mok C.C., Chan T.M., Wong R.W., Mok M.Y., Lee K.W., Wong S.N., Leung A.M., Li X.P., Avihingsanon Y., Rianthavorn P., Deekajorndej T., Suphapeetiporn K., Shotelersuk V., Baum L., Kwan P., Lee T.L., Ho M.H., Lee P.P., Wong W.H., Zeng S., Zhang J., Wong C.M., Ng I.O., Garcia-Barcelo M.M., Cherny S.S., Tam P.K., Sham P.C., Lau C.S., Lau Y.L. ELF1 is associated with systemic lupus erythematosus in Asian populations. Hum. Mol. Genet. 2011, 20:601-607.
14. Clancy R.M., Marion M.C., Kaufman K.M., Ramos P.S., Adler A., Harley J.B., Langefeld C.D., Buyon J.P. Identification of candidate loci at 6p21 and 21q22 in a genome-wide association study of cardiac manifestations of neonatal lupus. Arthritis Rheum. 2010, 62:3415-3424.
15. Kariuki S.N., Franek B.S., Kumar A.A., Arrington J., Mikolaitis R.A., Utset T.O., Jolly M., Crow M.K., Skol A.D., Niewold T.B. Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus. Arthritis Res. Ther. 2010, 12:R151.
16. Yang W., Shen N., Ye D.Q., Liu Q., Zhang Y., Qian X.X., Hirankarn N., Ying D., Pan H.F., Mok C.C., Chan T.M., Wong R.W., Lee K.W., Mok M.Y., Wong S.N., Leung A.M., Li X.P., Avihingsanon Y., Wong C.M., Lee T.L., Ho M.H., Lee P.P., Chang Y.K., Li P.H., Li R.J., Zhang L., Wong W.H., Ng I.O., Lau C.S., Sham P.C., Lau Y.L. Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet. 2010, 6:e1000841.
17. Han J.W., Zheng H.F., Cui Y., Sun L.D., Ye D.Q., Hu Z., Xu J.H., Cai Z.M., Huang W., Zhao G.P., Xie H.F., Fang H., Lu Q.J., Li X.P., Pan Y.F., Deng D.Q., Zeng F.Q., Ye Z.Z., Zhang X.Y., Wang Q.W., Hao F., Ma L., Zuo X.B., Zhou F.S., Du W.H., Cheng Y.L., Yang J.Q., Shen S.K., Li J., Sheng Y.J., Zuo X.X., Zhu W.F., Gao F., Zhang P.L., Guo Q., Li B., Gao M., Xiao F.L., Quan C., Zhang C., Zhang Z., Zhu K.J., Li Y., Hu D.Y., Lu W.S., Huang J.L., Liu S.X., Li H., Ren Y.Q., Wang Z.X., Yang C.J., Wang P.G., Zhou W.M., Lv Y.M., Zhang A.P., Zhang S.Q., Lin D., Low H.Q., Shen M., Zhai Z.F., Wang Y., Zhang F.Y., Yang S., Liu J.J., Zhang X.J. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat. Genet. 2009, 41:1234-1237.
18. Graham R.R., Cotsapas C., Davies L., Hackett R., Lessard C.J., Leon J.M., Burtt N.P., Guiducci C., Parkin M., Gates C., Plenge R.M., Behrens T.W., Wither J.E., Rioux J.D., Fortin P.R., Graham D.C., Wong A.K., Vyse T.J., Daly M.J., Altshuler D., Moser K.L., Gaffney P.M. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat. Genet. 2008, 40:1059-1061.
19. Harley J.B., Alarcon-Riquelme M.E., Criswell L.A., Jacob C.O., Kimberly R.P., Moser K.L., Tsao B.P., Vyse T.J., Langefeld C.D., Nath S.K., Guthridge J.M., Cobb B.L., Mirel D.B., Marion M.C., Williams A.H., Divers J., Wang W., Frank S.G., Namjou B., Gabriel S.B., Lee A.T., Gregersen P.K., Behrens T.W., Taylor K.E., Fernando M., Zidovetzki R., Gaffney P.M., Edberg J.C., Rioux J.D., Ojwang J.O., James J.A., Merrill J.T., Gilkeson G.S., Seldin M.F., Yin H., Baechler E.C., Li Q.Z., Wakeland E.K., Bruner G.R., Kaufman K.M., Kelly J.A. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat. Genet. 2008, 40:204-210.
20. Hom G., Graham R.R., Modrek B., Taylor K.E., Ortmann W., Garnier S., Lee A.T., Chung S.A., Ferreira R.C., Pant P.V., Ballinger D.G., Kosoy R., Demirci F.Y., Kamboh M.I., Kao A.H., Tian C., Gunnarsson I., Bengtsson A.A., Rantapaa-Dahlqvist S., Petri M., Manzi S., Seldin M.F., Ronnblom L., Syvanen A.C., Criswell L.A., Gregersen P.K., Behrens T.W. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N. Engl. J. Med. 2008, 358:900-909.
21. Kozyrev S.V., Abelson A.K., Wojcik J., Zaghlool A., Linga Reddy M.V., Sanchez E., Gunnarsson I., Svenungsson E., Sturfelt G., Jonsen A., Truedsson L., Pons-Estel B.A., Witte T., D'Alfonso S., Barizzone N., Danieli M.G., Gutierrez C., Suarez A., Junker P., Laustrup H., Gonzalez-Escribano M.F., Martin J., Abderrahim H., Alarcon-Riquelme M.E. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat. Genet. 2008, 40:211-216.
22. Cervino A.C., Tsinoremas N.F., Hoffman R.W. A genome-wide study of lupus: preliminary analysis and data release. Ann. N. Y. Acad. Sci. 2007, 1110:131-139.
23. Wang P., Zangerl B., Werner P., Mauldin E.A., Casal M.L. Familial cutaneous lupus erythematosus (CLE) in the German shorthaired pointer maps to CFA18, a canine orthologue to human CLE. Immunogenetics 2011, 63:197-207.
24. Fye J.M., Orebaugh C.D., Coffin S.R., Hollis T., Perrino F.W. Dominant mutation of the TREX1 exonuclease gene in lupus and Aicardi-Goutieres syndrome. J. Biol. Chem. 2011, 286:32373-32382.
25. Choi J.Y., Gao W., Odegard J., Shiah H.S., Kashgarian M., McNiff J.M., Baker D.C., Cheng Y.C., Craft J. Abrogation of skin disease in LUPUS-prone MRL/FASlpr mice by means of a novel tylophorine analog. Arthritis Rheum. 2006, 54:3277-3283.
26. Housman T.S., Jorizzo J.L., McCarty M.A., Grummer S.E., Fleischer A.B., Sutej P.G. Low-dose thalidomide therapy for refractory cutaneous lesions of lupus erythematosus. Arch. Dermatol. 2003, 139:50-54.
27. Massoud S., Kamila H., Sima S., Mohammad Javad Y., Zahra R., Maryam S., Habibollah E. Evaluation of the incidence of discoid lupus erythematosus in patients with systemic lupus erythematosus and its relationship to disease activity. J. Cutan. Med. Surg. 2014, 18:1-4.
28. Tebbe B., Orfanos C.E. Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus 1997, 6:96-104.
29. Dey-Rao R., Smith J.R., Chow S., Sinha A.A. Differential gene expression analysis in CCLE lesions provides new insights regarding the genetics basis of skin vs. systemic disease. Genomics 2014, 104:144-155.
30. Fagone P., Mangano K., Mammana S., Quattrocchi C., Magro G., Coco M., Imene S., Di Marco R., Nicoletti F. Acceleration of SLE-like syndrome development in NZBxNZW F1 mice by beta-glucan. Lupus 2014, 23:407-411.
31. Hodge D.L., Berthet C., Coppola V., Kastenmuller W., Buschman M.D., Schaughency P.M., Shirota H., Scarzello A.J., Subleski J.J., Anver M.R., Ortaldo J.R., Lin F., Reynolds D.A., Sanford M.E., Kaldis P., Tessarollo L., Klinman D.M., Young H.A. IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in mice. J. Autoimmun. 2014, 53:33-45.
32. Mak A., Kow N.Y. The pathology of T cells in systemic lupus erythematosus. J. Immunol. Res. 2014, 2014:419029.
33. Nelson P., Rylance P., Roden D., Trela M., Tugnet N. Viruses as potential pathogenic agents in systemic lupus erythematosus. Lupus 2014, 23:596-605.
34. Nikpour M., Dempsey A.A., Urowitz M.B., Gladman D.D., Barnes D.A. Association of a gene expression profile from whole blood with disease activity in systemic lupus erythematosus. Ann. Rheum. Dis. 2008, 67:1069-1075.
35. Lyons P.A., McKinney E.F., Rayner T.F., Hatton A., Woffendin H.B., Koukoulaki M., Freeman T.C., Jayne D.R., Chaudhry A.N., Smith K.G. Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis. Ann. Rheum. Dis. 2010, 69:1208-1213.
36. Allantaz F., Chaussabel D., Stichweh D., Bennett L., Allman W., Mejias A., Ardura M., Chung W., Smith E., Wise C., Palucka K., Ramilo O., Punaro M., Banchereau J., Pascual V. Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade. J. Exp. Med. 2007, 204:2131-2144.
37. Baechler E.C., Batliwalla F.M., Karypis G., Gaffney P.M., Ortmann W.A., Espe K.J., Shark K.B., Grande W.J., Hughes K.M., Kapur V., Gregersen P.K., Behrens T.W. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:2610-2615.
38. Pascual V., Banchereau J., Palucka A.K. The central role of dendritic cells and interferon-alpha in SLE. Curr. Opin. Rheumatol. 2003, 15:548-556.
39. Petri M., Singh S., Tesfasyone H., Dedrick R., Fry K., Lal P., Williams G., Bauer J., Gregersen P., Behrens T., Baechler E. Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus. Lupus 2009, 18:980-989.
40. Thibault D.L., Graham K.L., Lee L.Y., Balboni I., Hertzog P.J., Utz P.J. Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus. Arthritis Res. Ther. 2009, 11:R112.
41. Liu K., Li Q.Z., Delgado-Vega A.M., Abelson A.K., Sanchez E., Kelly J.A., Li L., Liu Y., Zhou J., Yan M., Ye Q., Liu S., Xie C., Zhou X.J., Chung S.A., Pons-Estel B., Witte T., de Ramon E., Bae S.C., Barizzone N., Sebastiani G.D., Merrill J.T., Gregersen P.K., Gilkeson G.G., Kimberly R.P., Vyse T.J., Kim I., D'Alfonso S., Martin J., Harley J.B., Criswell L.A., Wakeland E.K., Alarcon-Riquelme M.E., Mohan C. Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans. J. Clin. Invest. 2009, 119:911-923.
42. Bennett L., Palucka A.K., Arce E., Cantrell V., Borvak J., Banchereau J., Pascual V. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 2003, 197:711-723.
43. Han G.M., Chen S.L., Shen N., Ye S., Bao C.D., Gu Y.Y. Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray. Genes Immun. 2003, 4:177-186.
44. Crow M.K., Wohlgemuth J. Microarray analysis of gene expression in lupus. Arthritis Res. Ther. 2003, 5:279-287.
45. Arasappan D., Tong W., Mummaneni P., Fang H., Amur S. Meta-analysis of microarray data using a pathway-based approach identifies a 37-gene expression signature for systemic lupus erythematosus in human peripheral blood mononuclear cells. BMC Med. 2011, 9:65.
46. Cordova E.J., Martinez-Hernandez A., Ramirez-Bello J., Velazquez-Cruz R., Centeno F., Baca V., Orozco L. HMOX1 promoter (GT)n polymorphism is associated with childhood-onset systemic lupus erythematosus but not with juvenile rheumatoid arthritis in a Mexican population. Clin. Exp. Rheumatol. 2012, 30:297-301.
47. Mandel M., Gurevich M., Pauzner R., Kaminski N., Achiron A. Autoimmunity gene expression portrait: specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosus. Clin. Exp. Immunol. 2004, 138:164-167.
48. Matache C., Stefanescu M., Dragomir C., Tanaseanu S., Onu A., Ofiteru A., Szegli G. Matrix metalloproteinase-9 and its natural inhibitor TIMP-1 expressed or secreted by peripheral blood mononuclear cells from patients with systemic lupus erythematosus. J. Autoimmun. 2003, 20:323-331.
49. Robak E., Kulczycka L., Sysa-Jedrzejowska A., Wierzbowska A., Robak T. Circulating proangiogenic molecules PIGF, SDF-1 and sVCAM-1 in patients with systemic lupus erythematosus. Eur. Cytokine Netw. 2007, 18:181-187.
50. Taysi S., Polat M.F., Sari R.A., Bakan E. Serum adenosine deaminase and cytidine deaminase activities in patients with systemic lupus erythematosus. Clin. Chem. Lab. Med. CCLM/FESCC 2002, 40:493-495.
51. Egerer K., Feist E., Rohr U., Pruss A., Burmester G.R., Dorner T. Increased serum soluble CD14, ICAM-1 and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus. Lupus 2000, 9:614-621.
52. Nockher W.A., Wigand R., Schoeppe W., Scherberich J.E. Elevated levels of soluble CD14 in serum of patients with systemic lupus erythematosus. Clin. Exp. Immunol. 1994, 96:15-19.
53. Wang G., Pierangeli S.S., Papalardo E., Ansari G.A., Khan M.F. Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity. Arthritis Rheum. 2010, 62:2064-2072.
54. Zahn S., Graef M., Barchet W., Bieber T., Tuting T., Wenzel J. Nitrosative stress: a hallmark of the junctional inflammation in cutaneous lupus erythematosus. Clin. Exp. Dermatol. 2012, 38:96-97.
55. Morgan P.E., Sturgess A.D., Davies M.J. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus. Arthritis Rheum. 2005, 52:2069-2079.
56. Ryan B.J., Eggleton P. Detection and characterization of autoantibodies against modified self-proteins in SLE sera after exposure to reactive oxygen and nitrogen species. Methods Mol. Biol. 2014, 1134:163-171.
57. Azevedo P.C., Murphy G., Isenberg D.A. Pathology of systemic lupus erythematosus: the challenges ahead. Methods Mol. Biol. 2014, 1134:1-16.
58. Deng Y., Tsao B.P. Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat. Rev. Rheumatol. 2010, 6:683-692.
59. Ko K., Franek B.S., Marion M., Kaufman K.M., Langefeld C.D., Harley J.B., Niewold T.B. Genetic ancestry, serum interferon-alpha activity, and autoantibodies in systemic lupus erythematosus. J. Rheumatol. 2012, 39:1238-1240.
60. Ko K., Koldobskaya Y., Rosenzweig E., Niewold T.B. Activation of the interferon pathway is dependent upon autoantibodies in African-American SLE patients, but not in European-American SLE patients. Front. Immunol. 2013, 4:309.
61. Courtney P.A., Crockard A.D., Williamson K., Irvine A.E., Kennedy R.J., Bell A.L. Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann. Rheum. Dis. 1999, 58:309-314.
62. Lin J.H., Dutz J.P., Sontheimer R.D., Werth V.P. Pathophysiology of cutaneous lupus erythematosus. Clin. Rev. Allergy Immunol. 2007, 33:85-106.
63. Zamolo G., Coklo M., Santini Dusevic D., Kastelan M., Batinac T., Materljan E., Brumini G. Expression of p53 and apoptosis in discoid lupus erythematosus. Croat. Med. J. 2005, 46:678-684.
64. Braunstein I., Klein R., Okawa J., Werth V.P. The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score. Br. J. Dermatol. 2012, 166:971-975.
65. Toberer F., Sykora J., Gottel D., Hartschuh W., Werchau S., Enk A., Joos S., Krammer P.H., Kuhn A. Apoptotic signal molecules in skin biopsies of cutaneous lupus erythematosus: analysis using tissue microarray. Exp. Dermatol. 2013, 22:656-659.
66. Baima B., Sticherling M. Apoptosis in different cutaneous manifestations of lupus erythematosus. Br. J. Dermatol. 2001, 144:958-966.
67. Yu C., Chang C., Zhang J. Immunologic and genetic considerations of cutaneous lupus erythematosus: a comprehensive review. J. Autoimmun. 2013, 41:34-45.
68. Charles P.J. Defective waste disposal: does it induce autoantibodies in SLE?. Ann. Rheum. Dis. 2003, 62:1-3.
69. Rekvig O.P., Van der Vlag J. The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved. Semin. Immunopathol. 2014, 36:301-311.
70. Liu M., Xu H., Bashir M., Sharma M., Williams K., Anyanwu C., Okawa J., Werth V. Proinflammatory microvesicles in patients with cutaneous lupus erythematosus. J. Investig. Dermatol. 2014, 134:s13.
71. Crow M.K. Type I interferon in organ-targeted autoimmune and inflammatory diseases. Arthritis Res. Ther. 2010, 12(Suppl. 1):S5.
72. Crow M.K. Collaboration, genetic associations, and lupus erythematosus. N. Engl. J. Med. 2008, 358:956-961.
73. Wang C., Sandling J.K., Hagberg N., Berggren O., Sigurdsson S., Karlberg O., Ronnblom L., Eloranta M.L., Syvanen A.C. Genome-wide profiling of target genes for the systemic lupus erythematosus-associated transcription factors IRF5 and STAT4. Ann. Rheum. Dis. 2013, 72:96-103.
74. Begovich A.B., Carlton V.E., Honigberg L.A., Schrodi S.J., Chokkalingam A.P., Alexander H.C., Ardlie K.G., Huang Q., Smith A.M., Spoerke J.M., Conn M.T., Chang M., Chang S.Y., Saiki R.K., Catanese J.J., Leong D.U., Garcia V.E., McAllister L.B., Jeffery D.A., Lee A.T., Batliwalla F., Remmers E., Criswell L.A., Seldin M.F., Kastner D.L., Amos C.I., Sninsky J.J., Gregersen P.K. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 2004, 75:330-337.
75. Jabbari A., Suarez-Farinas M., Fuentes-Duculan J., Gonzalez J., Cueto I., Franks A.G., Krueger J.G. Dominant Th1 and minimal Th17 skewing in discoid lupus revealed by transcriptomic comparison with psoriasis. J. Invest. Dermatol. 2014, 134:87-95.
76. Wenzel J., Zahn S., Bieber T., Tuting T. Type I interferon-associated cytotoxic inflammation in cutaneous lupus erythematosus. Arch. Dermatol. Res. 2009, 301:83-86.
77. Dey-Rao R., Seiffert-Sinha K., Sinha A.A. Genome-wide expression analysis suggests unique disease-promoting and disease-preventing signatures in Pemphigus vulgaris. Genes Immun. 2013, 14:487-499.
78. Coda A.B., Icen M., Smith J.R., Sinha A.A. Global transcriptional analysis of psoriatic skin and blood confirms known disease-associated pathways and highlights novel genomic "hot spots" for differentially expressed genes. Genomics 2012, 100:18-26.
79. Coda A.B., Sinha A.A. Integration of genome-wide transcriptional and genetic profiles provides insights into disease development and clinical heterogeneity in alopecia areata. Genomics 2011, 98:431-439.
80. Wenzel J., Tuting T. Identification of type I interferon-associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches. Exp. Dermatol. 2007, 16:454-463.
81. Hooks J.J., Moutsopoulos H.M., Geis S.A., Stahl N.I., Decker J.L., Notkins A.L. Immune interferon in the circulation of patients with autoimmune disease. N. Engl. J. Med. 1979, 301:5-8.
82. Kuhn A., Wenzel J., Weyd H. Photosensitivity, apoptosis, and cytokines in the pathogenesis of lupus erythematosus: a critical review. Clin. Rev. Allergy Immunol. 2014, 47:148-162.
83. Sawalha A.H., Jeffries M., Webb R., Lu Q., Gorelik G., Ray D., Osban J., Knowlton N., Johnson K., Richardson B. Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients. Genes Immun. 2008, 9:368-378.
84. Kirou K.A., Lee C., George S., Louca K., Peterson M.G., Crow M.K. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum. 2005, 52:1491-1503.
85. Kuhn A., Herrmann M., Kleber S., Beckmann-Welle M., Fehsel K., Martin-Villalba A., Lehmann P., Ruzicka T., Krammer P.H., Kolb-Bachofen V. Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation. Arthritis Rheum. 2006, 54:939-950.
86. Coda A.B., Qafalijaj Hysa V., Seiffert-Sinha K., Sinha A.A. Peripheral blood gene expression in alopecia areata reveals molecular pathways distinguishing heritability, disease and severity. Genes Immun. 2010, 11:531-541.
87. Sun C.J., Zhang L., Zhang W.Y. Gene expression profiling of maternal blood in early onset severe preeclampsia: identification of novel biomarkers. J. Perinat. Med. 2009, 37:609-616.
88. Edwards C.J., Feldman J.L., Beech J., Shields K.M., Stover J.A., Trepicchio W.L., Larsen G., Foxwell B.M., Brennan F.M., Feldmann M., Pittman D.D. Molecular profile of peripheral blood mononuclear cells from patients with rheumatoid arthritis. Mol. Med. 2007, 13:40-58.
89. Subramanya R.D., Coda A.B., Sinha A.A. Transcriptional profiling in alopecia areata defines immune and cell cycle control related genes within disease-specific signatures. Genomics 2010, 96:146-153.
90. Schadt E.E., Li C., Ellis B., Wong W.H. Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data. J. Cell. Biochem. Suppl. 2001, 37:120-125.